Stay updated with breaking news from Avidd Centers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, recently awarded more than $12 million to three institutions for the development of antiviral therapies to treat diseases caused by viruses with pandemic potential.
The multidisciplinary center will focus on the development of antiviral drugs to combat coronaviruses and other viruses with pandemic potential.
A major new antiviral drug development center led by Scripps Research in La Jolla to prime for the next pandemic is getting a $67 million award over three years from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, with potential renewal for two additional years.